Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Jens Schroeder Kemp to the newly created role of Chief Marketing Officer. Kemp brings more than 20 years of strategic marketing, sales, and business development experience in high-growing medical technology. As a member of the Axogen executive leadership team, Kemp will report directly to Karen Zaderej, Chairman, CEO and President, and will oversee the development and execution of the company’s marketing strategies.
Related news for (AXGN)
- Axogen Announces Chief Financial Officer Transition
- Axogen, Inc. Reports 2025 First Quarter Financial Results
- Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
- Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
- axogen completes submission of biologics license application to u.s. food and drug administration for avance nerve graft®